ANCA Vasculitis Drug Market
According to Intent Market Research, the Anca Vasculitis Drug Market is expected to grow from USD 0.4 Billion in 2024-e at a CAGR of 10.7% to touch USD 0.8 Billion by 2030. The Anca Vasculitis Drug Market is dominated by key players such as, GlaxoSmithKline, Pfizer, Novartis, Bristol-Myers Squibb, Roche, and AbbVie.